A detailed history of Arete Wealth Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Arete Wealth Advisors, LLC holds 3,439 shares of EW stock, worth $233,026. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,439
Previous 3,589 4.18%
Holding current value
$233,026
Previous $332,000 32.23%
% of portfolio
0.02%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$59.7 - $93.78 $8,955 - $14,067
-150 Reduced 4.18%
3,439 $225,000
Q2 2024

Aug 13, 2024

BUY
$84.3 - $94.31 $302,552 - $338,478
3,589 New
3,589 $332,000
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $6,664 - $8,398
108 Added 2.78%
3,988 $304,000
Q3 2023

Oct 30, 2023

SELL
$69.28 - $93.38 $23,832 - $32,122
-344 Reduced 8.14%
3,880 $268,000
Q2 2023

Aug 09, 2023

SELL
$81.41 - $94.33 $283,958 - $329,023
-3,488 Reduced 45.23%
4,224 $398,000
Q1 2023

May 01, 2023

BUY
$74.26 - $84.51 $5,272 - $6,000
71 Added 0.93%
7,712 $638,000
Q4 2022

Feb 06, 2023

BUY
$68.3 - $87.44 $148,415 - $190,007
2,173 Added 39.74%
7,641 $570,000
Q3 2022

Nov 07, 2022

SELL
$82.37 - $107.29 $329 - $429
-4 Reduced 0.07%
5,468 $452,000
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $23,355 - $34,632
-270 Reduced 4.7%
5,472 $520,000
Q1 2022

May 06, 2022

SELL
$101.96 - $128.34 $51,183 - $64,426
-502 Reduced 8.04%
5,742 $676,000
Q4 2021

Feb 07, 2022

BUY
$106.37 - $130.68 $63,290 - $77,754
595 Added 10.53%
6,244 $802,000
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $57,115 - $68,126
555 Added 10.9%
5,649 $640,000
Q2 2021

Aug 09, 2021

BUY
$83.84 - $104.76 $9,054 - $11,314
108 Added 2.17%
5,094 $460,000
Q1 2021

May 10, 2021

BUY
$78.68 - $90.67 $9,835 - $11,333
125 Added 2.57%
4,986 $417,000
Q4 2020

Feb 08, 2021

BUY
$71.69 - $91.23 $9,104 - $11,586
127 Added 2.68%
4,861 $442,000
Q3 2020

Nov 09, 2020

BUY
$67.19 - $87.44 $26,204 - $34,101
390 Added 8.98%
4,734 $373,000
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $171,699 - $229,618
2,984 Added 219.41%
4,344 $300,000
Q1 2020

May 14, 2020

SELL
$52.41 - $81.0 $11,897 - $18,387
-227 Reduced 14.3%
1,360 $257,000
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $7,170 - $8,209
-100 Reduced 5.93%
1,587 $370,000
Q3 2019

Nov 13, 2019

BUY
$61.55 - $75.43 $9,417 - $11,540
153 Added 9.97%
1,687 $371,000
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $6,187 - $7,149
111 Added 7.8%
1,534 $283,000
Q1 2019

May 15, 2019

SELL
$47.89 - $64.05 $478 - $640
-10 Reduced 0.7%
1,423 $272,000
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $65,488 - $83,156
1,433 New
1,433 $249,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Arete Wealth Advisors, LLC Portfolio

Follow Arete Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arete Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arete Wealth Advisors, LLC with notifications on news.